Mode
Text Size
Log in / Sign up
Phase 4 N=50 Randomized Quadruple-blind Treatment

Continuous Wound Infiltration After Hallux Valgus Surgery

Hallux Valgus

Enrolled (actual)
50
Serious AEs
4.0%
Results posted
Aug 2018
Primary outcome: Primary: Average Postoperative Numeric Rating Scale (NRS) for Pain — 2.0; 1.9 units on a scale — p=0.596

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Wound infiltration catheter (Device); NaCl 0.9% (Drug); Ropivacaine 0.2% (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Medical University Innsbruck
Primary completion
Apr 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Average Postoperative Numeric Rating Scale (NRS) for Pain
2.0; 1.9 0.596
PRIMARY
Peak Postoperative Numeric Rating Scale (NRS) for Pain
3.9; 3.5 0.353
SECONDARY
American Orthopaedic Foot and Ankle Society Score (AOFAS)
75.8; 75.7
SECONDARY
Patient's Overall Satisfaction With Surgery
9.1; 9.0
SECONDARY
Patient's Overall Satisfaction With Pain Management
9.3; 9.0

Summary

The aim of this study is to investigate the effect of continuous wound infiltration with ropivacaine in comparison to standard pain management after elective distal metatarsal osteotomy for postoperative pain control.

Eligibility Criteria

Inclusion Criteria

  • All patients undergoing a distal metatarsal osteotomy (only Chevron or Scarf) and lateral release of the adductor halluces muscle with/without concomitant osteotomy of the proximal phalanx of the greater toe (Akin) for idiopathic hallux valgus deformity will be included.

Exclusion Criteria

  • hallux valgus surgery other then mentioned above or concomitant other procedures
  • denial to participate and give informed consent
  • patients with neurological diseases that affect the sensory-motor function
  • patients with any short-term (1 month) previous surgery on affected lower extremity
  • allergies or other comorbidity that prohibits standardized pain regime (renal insufficiency, severe heart or liver impairment, uncontrolled asthma, history of peptic ulcera )
  • patients unwilling to undergo surgery without general anesthesia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02182999). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search